$5 million supports research into neglected tropical diseases
(Washington University School of Medicine) Researchers at Washington University School of Medicine in St. Louis have received two grants from the National Institutes of Health (NIH) totaling more than $5 million to study two types of parasitic worm infection that cause devastating illness in millions of people worldwide. One project will focus on onchocerciasis, commonly known as river blindness. The second project will target fascioliasis, commonly found in cattle-farming operations. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 21, 2020 Category: Infectious Diseases Source Type: news
Researchers describe the mechanism of a protein upon infection of the 'Fasciola hepatica'
(University of C ó rdoba) The study also validated ten reference genes in sheep that allow for studying how the immune system behaves when facing this disease (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 22, 2019 Category: Biology Source Type: news
Novartis receives FDA approval for Egaten ® for the treatment of fascioliasis, a neglected tropical disease
Novartis announced that the US Food and Drug Administration (FDA) has approved Egaten® (triclabendazole) for the treatment of fascioliasis in patients six years of age and older. This makes Egaten the only FDA-approved drug for people with this disease and is expected to facilitate broader access to this important drug not only in the US, but also in affected countries worldwide. (Source: World Pharma News)
Source: World Pharma News - February 18, 2019 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news
FDA OKs Triclabendazole for Tropical Disease Fascioliasis FDA OKs Triclabendazole for Tropical Disease Fascioliasis
Fascioliasis (liver fluke infestation) is a waterborne and foodborne neglected tropical disease affecting an estimated 2.4 million people worldwide, with an additional 180 million at risk.FDA Approvals (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - February 16, 2019 Category: Respiratory Medicine Tags: Infectious Diseases News Alert Source Type: news
FDA Approves Egaten (triclabendazole) for the Treatment of Fascioliasis, a Neglected Tropical Disease
Basel, Switzerland, February 13, 2019 - Novartis announced today that the US Food and Drug Administration (FDA) has approved Egaten (triclabendazole) for the treatment of fascioliasis in patients six years of age and older. This makes Egaten the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 13, 2019 Category: Drugs & Pharmacology Source Type: news
Novartis renews drug donation of Egaten ® (triclabendazole) until 2022
Novartis reaffirms its commitment to the fight against liver fluke (fascioliasis), signing a renewed memorandum of understanding with the World Health Organization (WHO) to extend its drug donation for Egaten® (triclabendazole) until 2022. Egaten is currently the only treatment for fascioliasis recommended by the WHO and is on the WHO Model List of Essential Medicines. (Source: World Pharma News)
Source: World Pharma News - July 23, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news
Compound in trendy goji berries could treat deadly tropical diseases
Researchers from Cardiff University found that the compound attacks the coating of the parasites responsible for the life-threatening infections schistosomiasis and fascioliasis. (Source: the Mail online | Health)
Source: the Mail online | Health - July 5, 2018 Category: Consumer Health News Source Type: news
Compound in trendy goji berries could treat deadly tropical diseases
Researchers from Cardiff University found that the compound attacks the coating of the parasites responsible for the life-threatening infections schistosomiasis and fascioliasis. (Source: the Mail online | Health)
Source: the Mail online | Health - July 5, 2018 Category: Consumer Health News Source Type: news
Compound in trendy goji berries could treat two deadly tropical diseases
Researchers from Cardiff University found that the compound attacks the coating of the parasites responsible for the life-threatening infections schistosomiasis and fascioliasis. (Source: the Mail online | Health)
Source: the Mail online | Health - July 5, 2018 Category: Consumer Health News Source Type: news
Plan of Action for the Elimination of Neglected Infectious Diseases and Post-Elimination Actions 2016-2022
World Health Organization, Pan American Health Organization. 07/07/2016 This 33-page document, prepared for the 68th Session of the Regional Committee of the World Health Organization for the Americas in September 2016, provides a six-year Plan of Action for neglected infectious diseases (NIDs) that proposes up-to-date lines of action to reduce morbidity, disability, and mortality; and to more rapidly advance efforts to eliminate NIDs as public health problems and stop NID transmission. It will address the surveillance, management, control, and elimination of 13 diseases: blinding trachoma, Chagas disease, cystic echinococ...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - October 1, 2016 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news
Fascioliasis: A Rare Cause of Liver AbscessFascioliasis: A Rare Cause of Liver Abscess
This rare case describes a patient who presented with a liver abscess associated with fascioliasis. Would you recognize it? Postgraduate Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 17, 2014 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
